LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 185 filers reported holding LEMAITRE VASCULAR INC in Q1 2023. The put-call ratio across all filers is 16.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,186,201 | +0.2% | 21,761 | +23.7% | 0.00% | 0.0% |
| Q2 2023 | $1,184,074 | -1.2% | 17,589 | -24.4% | 0.00% | 0.0% |
| Q1 2023 | $1,198,511 | +16.7% | 23,278 | +4.3% | 0.00% | 0.0% |
| Q4 2022 | $1,027,000 | -7.6% | 22,313 | +1.8% | 0.00% | -33.3% |
| Q3 2022 | $1,111,000 | +16.0% | 21,927 | +4.4% | 0.00% | +50.0% |
| Q2 2022 | $958,000 | +10.9% | 21,009 | +13.1% | 0.00% | 0.0% |
| Q1 2022 | $864,000 | -1.3% | 18,581 | +6.6% | 0.00% | 0.0% |
| Q4 2021 | $875,000 | +2.6% | 17,424 | +8.5% | 0.00% | 0.0% |
| Q3 2021 | $853,000 | -10.3% | 16,065 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $951,000 | +34.1% | 15,588 | +7.2% | 0.00% | 0.0% |
| Q1 2021 | $709,000 | +15.5% | 14,536 | -4.2% | 0.00% | 0.0% |
| Q4 2020 | $614,000 | +30.9% | 15,175 | +4.7% | 0.00% | +100.0% |
| Q3 2020 | $469,000 | +62.8% | 14,494 | +32.9% | 0.00% | 0.0% |
| Q2 2020 | $288,000 | +85.8% | 10,902 | +75.2% | 0.00% | 0.0% |
| Q1 2020 | $155,000 | – | 6,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |